M3 Stock price
AI Insights on M3
Insights
Is M3 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
M3 Stock Analysis
Analyst Opinions
17 Analysts have issued a M3 forecast:
Analyst Opinions
17 Analysts have issued a M3 forecast:
Don't miss a Thing! We will send you all news about M3 directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.
| Head office | Japan |
| CEO | Itaru Tanimura |
| Employees | 15,360 |
| Founded | 2000 |
| Website | corporate.m3.com |


